Source:http://linkedlifedata.com/resource/pubmed/id/19553057
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0006812,
umls-concept:C0008565,
umls-concept:C0022947,
umls-concept:C0032105,
umls-concept:C0086418,
umls-concept:C0376315,
umls-concept:C0439810,
umls-concept:C0680730,
umls-concept:C0870883,
umls-concept:C0969276,
umls-concept:C1148554,
umls-concept:C1455513,
umls-concept:C1511790,
umls-concept:C1527240,
umls-concept:C2743996
|
pubmed:issue |
3
|
pubmed:dateCreated |
2009-7-20
|
pubmed:abstractText |
A new sensitive high-performance liquid chromatographic (HPLC) method for the determination of gimatecan (ST1481), a new camptothecin derivative, and its metabolite (ST1698) in plasma sample has been developed. The method consisted of on-line column solid phase extraction of analytes from human plasma, chromatographic separation by isocratic elution, then fluorimetric detection. The limits of quantitation were 0.25 ng/mL for both the analytes. The recovery of the extraction procedure was in the range of 62.8-71.1% for all the compounds. Good linearity (R(2)>0.999) was observed within the calibration ranges studied: 0.25-25 ng/mL for both ST1481 and ST1698. Precision was in the range 1.2-4.3%, and accuracy was always lower than 4.7%. Surprisingly, after administration of ST1481 to humans, plasma concentrations found were higher than expected, while metabolite plasma concentrations were negligible. For this reason, a second calibration curve range was validated to quantify ST1481 in human plasma, ranging from 5 to 200 ng/mL. A good accuracy and precision were obtained, confirming the usefulness of the procedure. By using neutral analytical condition the intact lactone form was estimated in plasma samples from a patient. The lactone form amounted to 80-100% of the total ST1481.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1873-264X
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
50
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
507-14
|
pubmed:meshHeading |
pubmed-meshheading:19553057-Antineoplastic Agents,
pubmed-meshheading:19553057-Camptothecin,
pubmed-meshheading:19553057-Chromatography, High Pressure Liquid,
pubmed-meshheading:19553057-Clinical Trials, Phase I as Topic,
pubmed-meshheading:19553057-Enzyme Inhibitors,
pubmed-meshheading:19553057-Humans,
pubmed-meshheading:19553057-Reproducibility of Results
|
pubmed:year |
2009
|
pubmed:articleTitle |
Determination of total and lactone form of a new camptothecin derivative gimatecan (ST1481) and its metabolite ST1698 in human plasma by high-performance liquid chromatography with fluorimetric detection.
|
pubmed:affiliation |
Research and Development Division, Department of Pharmacokinetics and Metabolism, sigma-tau Industrie Farmaceutiche Riunite, via Pontina Km 30,400, 00040 Pomezia, Rome, Italy.
|
pubmed:publicationType |
Journal Article,
Validation Studies
|